Brandywine Realty Trust
F:B2X

Watchlist Manager
Brandywine Realty Trust Logo
Brandywine Realty Trust
F:B2X
Watchlist
Price: 2.6 EUR -0.99% Market Closed
Market Cap: €447.9m

Brandywine Realty Trust
Investor Relations

Brandywine Realty Trust is a real estate investment trust that owns, develops, leases, and manages office buildings. Its properties are mainly in large job centers such as the Philadelphia region, the Washington, D.C. area, and parts of Texas. The company’s business is simple: it buys land or buildings, improves them, and rents space to tenants who need offices and related services. Its customers are businesses and government-related tenants that sign lease agreements for office space. Brandywine makes money mostly from rent, along with fees tied to property management, development, and tenant improvements. Because office buildings need ongoing upkeep and leasing work, the company also spends heavily on maintaining properties, attracting tenants, and keeping buildings competitive for long-term use. What makes Brandywine different is that it sits in the middle of the office real estate value chain: it does not just own buildings, it also develops and manages them. That gives it more control over how its properties are designed, leased, and operated. As a REIT, it is built to pass most of its cash flow through to shareholders, so its business is closely tied to the health of office demand and the quality of its property portfolio.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Apr 23, 2026
AI Summary
Q1 2026

Results in line: Brandywine said first-quarter results were in line with its business plan, with FFO of $0.11 per share, matching consensus and management guidance, while the company kept its full-year operating and financial plan unchanged.

Asset sales progressing: The company has about $305 million of potential sales under agreement or in due diligence, with most closings expected in the next 60 to 90 days and proceeds aimed mainly at debt reduction.

Occupancy improving: The core portfolio was 88.3% occupied and 89.9% leased, with management pointing to stronger leasing momentum, especially in Philadelphia, and expecting positive net absorption for the first time in several years.

Balance sheet focus: Management repeatedly emphasized that lowering leverage and getting back to investment-grade metrics is the top priority, even as it also considers share repurchases if asset-sale pricing stays favorable.

Development pipeline: Leasing momentum continues at One Uptown and 3151, and the company sees early signs of improvement in Philadelphia life science demand, though lease-up timing remains a key hurdle.

Guidance intact: Full-year FFO guidance was narrowed but the midpoint stayed at $0.55, and second-quarter guidance points to higher property-level operating income and continued balance-sheet activity.

Key Financials
FFO per share
$0.11
Net loss per share
$0.28
Net loss
$48.9 million
Property level NOI
$70.2 million
Core Portfolio occupancy
88.3%
Core Portfolio leased
89.9%
Same-store NOI
0.8%
Same-store NOI cash basis
3.3%
Leasing activity
422,000 square feet
Spec revenue target achieved
94%
Tenant retention
45%
Capital ratio
6.4%
GAAP mark-to-market
4.1%
Cash mark-to-market
-2.6%
Philadelphia occupancy
94%
Philadelphia leased
96%
Commerce Square leased
93%
Overall Philadelphia holdings leased
95%
Austin occupied
70%
Operating portfolio leasing pipeline
1.7 million square feet
Advanced negotiations pipeline
314,000 square feet
Cash on hand
$36 million
Line of credit outstanding
$65 million
Potential sales
$305 million
Second quarter property level operating income
$72.3 million
Second quarter G&A expense
$9.5 million
Second quarter interest expense
$43 million
Second quarter share count
180 million
Annualized combined debt to EBITDA
9.1x
Annualized core net debt to EBITDA
8.3x
Expected net debt to EBITDA
8.4x to 8.8x
Expected fixed charge coverage
1.8x to 2.0x
3025 JFK financing
$100 million
ATX recapitalization cash proceeds
$40 million to $50 million
Capital plan
$450 million
Payout ratio
92.7%
Development spend
$50 million
Common dividends
$42 million
Revenue maintain
$25 million
Revenue create
$25 million
Equity contributions
$15 million
Cash flow after interest payments
$80 million
Avira residential project financing
$100 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Gerard H. Sweeney
President, CEO & Trustee
No Bio Available
Mr. Thomas E. Wirth CPA
Executive VP & CFO
No Bio Available
Mr. George D. Johnstone
Executive Vice President of Operations
No Bio Available
Mr. H. Jeffrey DeVuono
Executive VP & Senior MD of Life Sciences
No Bio Available
Mr. William D. Redd
Executive VP & Senior MD of Austin, Metro DC & Richmond Regions
No Bio Available
Mr. George S. Hasenecz
Senior Vice President of Investments
No Bio Available
Mr. Daniel Palazzo CPA
Senior VP, Chief Accounting Officer & Treasurer
No Bio Available
Mr. James Kurek
VP and Chief Technology & Innovation Officer
No Bio Available
Mr. Shawn Neuman J.D.
Senior VP, General Counsel & Secretary
No Bio Available
Ms. Laura Krebs Miller
Vice President of Marketing, Media & Brand Management
No Bio Available

Contacts

Address
PENNSYLVANIA
PHILADELPHIA
2929 Arch Street, Suite 1800
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett